The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The transition of adjuvant chemotherapy for stage III colorectal cancer: A single institute experience in Japan.
 
Hiroki Osumi
No Relationships to Disclose
 
Eiji Shinozaki
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Mitsukuni Suenaga
No Relationships to Disclose
 
Satoshi Matsusaka
Research Funding - Taiho Pharmaceutical (Inst)
 
Mariko Ogura
No Relationships to Disclose
 
Masato Ozaka
No Relationships to Disclose
 
Yosuke Kumekawa
No Relationships to Disclose
 
Keisho Chin
No Relationships to Disclose
 
Yoshiya Fujimoto
No Relationships to Disclose
 
Masashi Ueno
No Relationships to Disclose
 
Nobuyuki Mizunuma
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)